Semaglutide

The study involved 17,604 adults with pre-existing cardiovascular disease who were overweight or obese, but without diabetes. Patients treated with Wegovy showed an average weight loss of 10.2% after 208 weeks, while those in the placebo group lost only 1.5% of their initial weight. Type 2 diabetes is a disease in which the body does […]